Pharmaceutical Analytical Testing Services In CRO Market
授權報價
| Single User License | $5,950 USD |
| Enterprise License | $6,950 USD |
| Corporate User License | $8,950 USD |
完整報告名稱與涵蓋範圍
Pharmaceutical Analytical Testing Services In CRO Market Size, Share & Trends Analysis Report By Service (Bioanalytical Testing, Method Development & Validation), By End-use (Pharmaceutical Companies, Biopharmaceutical Companies), By Region, And Segment Forecasts, 2026 - 2033
報告摘要
Pharmaceutical Analytical Testing Services In CRO Market Summary
The global pharmaceutical analytical testing services in CRO market size was valued at USD 8.0 billion in 2025 and is projected to grow from USD 8.7 billion in 2026 to USD 15.9 billion by 2033, at a CAGR of 9.1% from 2026 to 2033. North America dominated the market, accounting for the largest share of 37.2% in 2025.
The pharmaceutical analytical testing services in CRO industry is anticipated to grow over the forecast period owing to increasing outsourcing of analytical testing by pharmaceutical and biotechnology companies, stringent global regulatory requirements for product quality and safety, rising development of biologics, biosimilars, and advanced therapies, growing pharmaceutical research and development activities, and expanding demand for specialized analytical capabilities across the drug development lifecycle. The market growth is further supported by the need to reduce development timelines, optimize operational costs, and access advanced analytical technologies without major capital investment. The increasing complexity of pharmaceutical formulations and regulatory expectations continues to drive the outsourcing of analytical testing services to specialized CROs.
The increasing outsourcing of pharmaceutical analytical testing remains one of the primary growth drivers for the market. The growing complexity of drug development, coupled with strict regulatory requirements for analytical method validation, stability testing, impurity profiling, and bioanalytical assessments, has encouraged pharmaceutical companies to partner with specialized CROs that offer advanced laboratory infrastructure and regulatory expertise. The outsourcing model enables companies to reduce operational costs, improve resource utilization, and accelerate product development timelines while maintaining regulatory compliance. For instance, in May 2025, SGS announced ISO 17025 accreditation for its pharmaceutical laboratory in Mississauga, Canada, enabling the facility to provide extractables and leachables testing services for pharmaceutical, biopharmaceutical, and medical device manufacturers across North America, thereby expanding analytical testing capacity to address increasing client demand.
The increasing development of biologics, biosimilars, cell and gene therapies, and other complex drug modalities is another significant factor supporting market growth. These products require sophisticated analytical characterization, bioanalytical testing, stability assessment, and regulatory documentation throughout development and commercialization, creating sustained demand for specialized CRO services. The growing number of clinical development programs involving complex biologics has further increased the need for advanced analytical technologies and scientific expertise. For instance, in June 2025, Svar Life Science and Lablytica Life Science entered a strategic partnership to expand regulated bioanalytical services with advanced LC-MS-MS capabilities for pharmacokinetic, pharmacodynamic, biomarker quantification, and therapeutic drug monitoring studies across drug discovery and clinical development programs.
The market growth is moderated by high investment requirements for advanced analytical laboratories, evolving regulatory expectations, and the limited availability of highly skilled analytical scientists with expertise in complex testing methodologies. The increasing pipeline of biologics and advanced therapies, continued outsourcing by emerging biotechnology companies, and ongoing investments in analytical laboratory expansion and regulatory consulting services are expected to create significant growth opportunities for pharmaceutical analytical testing service providers. The combination of increasing pharmaceutical outsourcing, expanding biologics development, stringent quality requirements, and continuous investments in analytical capabilities is expected to support the sustained market growth over the forecast period.
Global Pharmaceutical Analytical Testing Services In CRO Market Report Segmentation
This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global pharmaceutical analytical testing services in CRO market report based on service, end-use, and region:
• Service Outlook (Revenue, USD Million, 2021 - 2033)
• Bioanalytical Testing
o Clinical
o Non-Clinical
• Method Development & Validation
o Extractable & Leachable
o Impurity Method
o Technical Consulting
o Others
• Stability Testing
o Drug Substance
o Stability Indicating Method Validation
o Accelerated Stability Testing
o Photostability Testing
o Others
• Others
• End-use Outlook (Revenue, USD Million, 2021 - 2033)
• Pharmaceutical Companies
• Biopharmaceutical Companies
• Others
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
o U.S.
o Canada
o Mexico
• Europe
o UK
o Germany
o France
o Italy
o Spain
o Denmark
o Sweden
o Norway
o Poland
o Switzerland
o Austria
o Czech Republic
o Croatia
o Slovenia
o Greece
• Asia Pacific
o Japan
o China
o India
o Australia
o Thailand
o South Korea
• Latin America
o Brazil
o Argentina
• Middle East & Africa
o South Africa
o UAE
o Saudi Arabia
o Kuwait
o Qatar
o Oman
目錄 Table of Contents
Table of Contents
Chapter 1. Research Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Service
1.2.2. End Use
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. GVR’s Internal Database
1.4.3. Secondary Sources
1.4.4. Primary Research
1.5. Information Or Data Analysis
1.5.1. Data Analysis Models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity Flow Analysis
1.7.2. Top-Down Analysis
1.7.3. Bottom-Up Approach
1.7.4. Multivariate Analysis
1.8. List Of Secondary Sources
1.9. List Of Abbreviations
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Pharmaceutical Analytical Testing Services in CRO Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.2.3. Market Opportunity Analysis
3.2.4. Market Challenge Analysis
3.3. Technology Landscape
3.4. Pricing Model Analysis
3.5. Tariff Impact Analysis
3.6. Market Analysis Tools
3.6.1. Porter’s Five Force Analysis
3.6.2. PESTEL by SWOT Analysis
Chapter 4. Pharmaceutical Analytical Testing Services in CRO Market: Service Estimates & Trend Analysis
4.1. Pharmaceutical Analytical Testing Services in CRO Market, By Service: Segment Dashboard
4.2. Pharmaceutical Analytical Testing Services in CRO Market, By Service: Movement Analysis
4.3. Pharmaceutical Analytical Testing Services in CRO Market Estimates & Forecasts, By Service, 2021 - 2033 (USD Million)
4.4. Bioanalytical Testing
4.4.1. Bioanalytical Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.4.2. Clinical
4.4.2.1. Clinical Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.4.3. Non-Clinical
4.4.3.1. Non-Clinical Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5. Method Development & Validation
4.5.1. Method Development & Validation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5.2. Extractable & Leachable
4.5.2.1. Extractable & Leachable Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5.3. Impurity Method
4.5.3.1. Impurity Method Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5.4. Technical Consulting
4.5.4.1. Technical Consulting Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5.5. Others
4.5.5.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.6. Stability Testing
4.6.1. Stability Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.6.2. Drug Substance
4.6.2.1. Drug Substance Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.6.3. Stability Indicating Method Validation
4.6.3.1. Stability Indicating Method Validation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.6.4. Accelerated Stability Testing
4.6.4.1. Accelerated Stability Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.6.5. Photostability Testing
4.6.5.1. Photostability Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.6.6. Others
4.6.6.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.7. Others
4.7.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 5. Pharmaceutical Analytical Testing Services in CRO Market: End Use Estimates & Trend Analysis
5.1. Pharmaceutical Analytical Testing Services in CRO Market, By End Use: Segment Dashboard
5.2. Pharmaceutical Analytical Testing Services in CRO Market, By End Use: Movement Analysis
5.3. Pharmaceutical Analytical Testing Services in CRO Market Estimates & Forecasts, By End Use, 2021 - 2033 (USD Million)
5.4. Pharmaceutical Companies
5.4.1. Pharmaceutical Companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.5. Biopharmaceutical Companies
5.5.1. Biopharmaceutical Companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.6. Others
5.6.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 6. Pharmaceutical Analytical Testing Services in CRO Market: Regional Estimates & Trend Analysis
6.1. Regional Market Dashboard
6.2. Regional Market Share Analysis, 2025 & 2033
6.3. North America
6.3.1. North America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.3.2. U.S
6.3.2.1. Key Country Dynamics
6.3.2.2. Competitive Scenario
6.3.2.3. Regulatory Framework
6.3.2.4. U.S. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.3.3. Canada
6.3.3.1. Key Country Dynamics
6.3.3.2. Competitive Scenario
6.3.3.3. Regulatory Framework
6.3.3.4. Canada Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.3.4. Mexico
6.3.4.1. Key Country Dynamics
6.3.4.2. Competitive Scenario
6.3.4.3. Regulatory Framework
6.3.4.4. Mexico Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.4. Europe
6.4.1. Europe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.4.2. UK
6.4.2.1. Key Country Dynamics
6.4.2.2. Competitive Scenario
6.4.2.3. Regulatory Framework
6.4.2.4. UK Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.4.3. Germany
6.4.3.1. Key Country Dynamics
6.4.3.2. Competitive Scenario
6.4.3.3. Regulatory Framework
6.4.3.4. Germany Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.4.4. France
6.4.4.1. Key Country Dynamics
6.4.4.2. Competitive Scenario
6.4.4.3. Regulatory Framework
6.4.4.4. France Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.4.5. Italy
6.4.5.1. Key Country Dynamics
6.4.5.2. Competitive Scenario
6.4.5.3. Regulatory Framework
6.4.5.4. Italy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.4.6. Spain
6.4.6.1. Key Country Dynamics
6.4.6.2. Competitive Scenario
6.4.6.3. Regulatory Framework
6.4.6.4. Spain Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.4.7. Denmark
6.4.7.1. Key Country Dynamics
6.4.7.2. Competitive Scenario
6.4.7.3. Regulatory Framework
6.4.7.4. Denmark Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.4.8. Sweden
6.4.8.1. Key Country Dynamics
6.4.8.2. Competitive Scenario
6.4.8.3. Regulatory Framework
6.4.8.4. Sweden Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.4.9. Norway
6.4.9.1. Key Country Dynamics
6.4.9.2. Competitive Scenario
6.4.9.3. Regulatory Framework
6.4.9.4. Norway Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.4.10. Poland
6.4.10.1. Key Country Dynamics
6.4.10.2. Competitive Scenario
6.4.10.3. Regulatory Framework
6.4.10.4. Poland Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.4.11. Switzerland
6.4.11.1. Key Country Dynamics
6.4.11.2. Competitive Scenario
6.4.11.3. Regulatory Framework
6.4.11.4. Switzerland Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.4.12. Austria
6.4.12.1. Key Country Dynamics
6.4.12.2. Competitive Scenario
6.4.12.3. Regulatory Framework
6.4.12.4. Austria Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.4.13. Czech Republic
6.4.13.1. Key Country Dynamics
6.4.13.2. Competitive Scenario
6.4.13.3. Regulatory Framework
6.4.13.4. Czech Republic Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.4.14. Croatia
6.4.14.1. Key Country Dynamics
6.4.14.2. Competitive Scenario
6.4.14.3. Regulatory Framework
6.4.14.4. Croatia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.4.15. Slovenia
6.4.15.1. Key Country Dynamics
6.4.15.2. Competitive Scenario
6.4.15.3. Regulatory Framework
6.4.15.4. Slovenia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.4.16. Greece
6.4.16.1. Key Country Dynamics
6.4.16.2. Competitive Scenario
6.4.16.3. Regulatory Framework
6.4.16.4. Greece Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5. Asia Pacific
6.5.1. Asia Pacific Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.2. Japan
6.5.2.1. Key Country Dynamics
6.5.2.2. Competitive Scenario
6.5.2.3. Regulatory Framework
6.5.2.4. Japan Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.3. China
6.5.3.1. Key Country Dynamics
6.5.3.2. Competitive Scenario
6.5.3.3. Regulatory Framework
6.5.3.4. China Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.4. India
6.5.4.1. Key Country Dynamics
6.5.4.2. Competitive Scenario
6.5.4.3. Regulatory Framework
6.5.4.4. India Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.5. Australia
6.5.5.1. Key Country Dynamics
6.5.5.2. Competitive Scenario
6.5.5.3. Regulatory Framework
6.5.5.4. Australia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.6. Thailand
6.5.6.1. Key Country Dynamics
6.5.6.2. Competitive Scenario
6.5.6.3. Regulatory Framework
6.5.6.4. Thailand Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.7. South Korea
6.5.7.1. Key Country Dynamics
6.5.7.2. Competitive Scenario
6.5.7.3. Regulatory Framework
6.5.7.4. South Korea Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6. Latin America
6.6.1. Latin America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6.2. Brazil
6.6.2.1. Key Country Dynamics
6.6.2.2. Competitive Scenario
6.6.2.3. Regulatory Framework
6.6.2.4. Brazil Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6.3. Argentina
6.6.3.1. Key Country Dynamics
6.6.3.2. Competitive Scenario
6.6.3.3. Regulatory Framework
6.6.3.4. Argentina Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.7. MEA
6.7.1. MEA Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.7.2. South Africa
6.7.2.1. Key Country Dynamics
6.7.2.2. Competitive Scenario
6.7.2.3. Regulatory Framework
6.7.2.4. South Africa Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.7.3. UAE
6.7.3.1. Key Country Dynamics
6.7.3.2. Competitive Scenario
6.7.3.3. Regulatory Framework
6.7.3.4. UAE Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.7.4. Saudi Arabia
6.7.4.1. Key Country Dynamics
6.7.4.2. Competitive Scenario
6.7.4.3. Regulatory Framework
6.7.4.4. Saudi Arabia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.7.5. Kuwait
6.7.5.1. Key Country Dynamics
6.7.5.2. Competitive Scenario
6.7.5.3. Regulatory Framework
6.7.5.4. Kuwait Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.7.6. Qatar
6.7.6.1. Key Country Dynamics
6.7.6.2. Competitive Scenario
6.7.6.3. Regulatory Framework
6.7.6.4. Qatar Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.7.7. Oman
6.7.7.1. Key Country Dynamics
6.7.7.2. Competitive Scenario
6.7.7.3. Regulatory Framework
6.7.7.4. Oman Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 7. Competitive Landscape
7.1. Key Participant Categorization
7.1.1. Market Leaders
7.1.2. Emerging Players
7.2. Market Share/Assessment Analysis, 2025 (Heat Map Analysis)
7.3. Company Profiles
7.3.1. SGS Société Générale de Surveillance SA
7.3.1.1. Company Overview
7.3.1.2. Financial Performance
7.3.1.3. Service Benchmarking
7.3.1.4. Strategic Initiatives
7.3.2. Worldwide Clinical Trials
7.3.2.1. Company Overview
7.3.2.2. Financial Performance
7.3.2.3. Service Benchmarking
7.3.2.4. Strategic Initiatives
7.3.3. Sofpromed
7.3.3.1. Company Overview
7.3.3.2. Financial Performance
7.3.3.3. Service Benchmarking
7.3.3.4. Strategic Initiatives
7.3.4. ClinChoice
7.3.4.1. Company Overview
7.3.4.2. Financial Performance
7.3.4.3. Service Benchmarking
7.3.4.4. Strategic Initiatives
7.3.5. Evotec
7.3.5.1. Company Overview
7.3.5.2. Financial Performance
7.3.5.3. Service Benchmarking
7.3.5.4. Strategic Initiatives
7.3.6. Eurofins Scientific
7.3.6.1. Company Overview
7.3.6.2. Financial Performance
7.3.6.3. Service Benchmarking
7.3.6.4. Strategic Initiatives
7.3.7. KYMOS Group
7.3.7.1. Company Overview
7.3.7.2. Financial Performance
7.3.7.3. Service Benchmarking
7.3.7.4. Strategic Initiatives
7.3.8. ViviaBiotech S.L.
7.3.8.1. Company Overview
7.3.8.2. Financial Performance
7.3.8.3. Service Benchmarking
7.3.8.4. Strategic Initiatives
7.3.9. GalChimia
7.3.9.1. Company Overview
7.3.9.2. Financial Performance
7.3.9.3. Service Benchmarking
7.3.9.4. Strategic Initiatives
7.3.10. TCI Laboratories
7.3.10.1. Company Overview
7.3.10.2. Financial Performance
7.3.10.3. Service Benchmarking
7.3.10.4. Strategic Initiatives
7.3.11. Cotecna (NEOTRON SpA,)
7.3.11.1. Company Overview
7.3.11.2. Financial Performance
7.3.11.3. Service Benchmarking
7.3.11.4. Strategic Initiatives
7.3.12. Tentamus
7.3.12.1. Company Overview
7.3.12.2. Financial Performance
7.3.12.3. Service Benchmarking
7.3.12.4. Strategic Initiatives
7.3.13. Enzymlogic
7.3.13.1. Company Overview
7.3.13.2. Financial Performance
7.3.13.3. Service Benchmarking
7.3.13.4. Strategic Initiatives
7.3.14. Pharmbiotest
7.3.14.1. Company Overview
7.3.14.2. Financial Performance
7.3.14.3. Service Benchmarking
7.3.14.4. Strategic Initiatives
7.3.15. UNIFARM - Research Centre
7.3.15.1. Company Overview
7.3.15.2. Financial Performance
7.3.15.3. Service Benchmarking
7.3.15.4. Strategic Initiatives
7.3.16. ANAPHARM EUROPE, S.L.U
7.3.16.1. Company Overview
7.3.16.2. Financial Performance
7.3.16.3. Service Benchmarking
7.3.16.4. Strategic Initiatives
圖表清單 List of Tables & Figures
List of Tables
Table 1. List of Secondary Sources
Table 2. List of Abbreviations
Table 3. Global Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Region, 2021 - 2033 (USD Million)
Table 4. Global Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
Table 5. Global Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
Table 6. North America Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
Table 7. North America Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
Table 8. North America Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
Table 9. U.S. Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
Table 10. U.S. Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
Table 11. Canada Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
Table 12. Canada Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
Table 13. Mexico Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
Table 14. Mexico Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
Table 15. Europe Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
Table 16. Europe Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
Table 17. Europe Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
Table 18. UK Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
Table 19. UK Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
Table 20. Germany Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
Table 21. Germany Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
Table 22. France Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
Table 23. France Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
Table 24. Italy Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
Table 25. Italy Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
Table 26. Spain Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
Table 27. Spain Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
Table 28. Denmark Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
Table 29. Denmark Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
Table 30. Sweden Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
Table 31. Sweden Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
Table 32. Norway Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
Table 33. Norway Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
Table 34. Poland Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
Table 35. Poland Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
Table 36. Switzerland Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
Table 37. Switzerland Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
Table 38. Austria Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
Table 39. Austria Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
Table 40. Czech Republic Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
Table 41. Czech Republic Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
Table 42. Croatia Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
Table 43. Croatia Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
Table 44. Slovenia Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
Table 45. Slovenia Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
Table 46. Greece Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
Table 47. Greece Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
Table 48. Asia Pacific Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
Table 49. Asia Pacific Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
Table 50. Asia Pacific Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
Table 51. Japan Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
Table 52. Japan Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
Table 53. China Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
Table 54. China Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
Table 55. India Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
Table 56. India Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
Table 57. Thailand Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
Table 58. Thailand Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
Table 59. South Korea Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
Table 60. South Korea Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
Table 61. Australia Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
Table 62. Australia Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
Table 63. Latin America Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
Table 64. Latin America Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
Table 65. Latin America Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
Table 66. Brazil Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
Table 67. Brazil Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
Table 68. Argentina Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
Table 69. Argentina Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
Table 70. Middle East & Africa Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
Table 71. Middle East & Africa Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
Table 72. Middle East & Africa Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
Table 73. South Africa Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
Table 74. South Africa Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
Table 75. Saudi Arabia Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
Table 76. Saudi Arabia Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
Table 77. UAE Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
Table 78. UAE Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
Table 79. Kuwait Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
Table 80. Kuwait Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
Table 81. Oman Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
Table 82. Oman Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
Table 83. Qatar Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
Table 84. Qatar Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Market formulation & validation
Fig. 6 Commodity flow analysis
Fig. 7 Value-chain-based sizing & forecasting
Fig. 8 QFD model sizing & forecasting
Fig. 9 Bottom-up approach
Fig. 10 Market snapshot
Fig. 11 Segment snapshot 1
Fig. 12 Segment snapshot 2
Fig. 13 Competitive landscape snapshot
Fig. 14 Parent market outlook, 2025 (USD Billion)
Fig. 15 Ancillary market outlook, 2025 (USD Billion)
Fig. 16 Pharmaceutical Analytical Testing Services in CRO Market Dynamics
Fig. 17 Porter’s five forces analysis
Fig. 18 PESTEL analysis
Fig. 19 Pharmaceutical Analytical Testing Services in CRO Market: Service outlook and key takeaways
Fig. 20 Pharmaceutical Analytical Testing Services in CRO Market: Service movement analysis
Fig. 21 Bioanalytical Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 22 Clinical Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 23 Non-Clinical Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 24 Method Development & Validation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 25 Extractable & Leachable Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 26 Impurity Method Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 27 Technical Consulting Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 28 Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 29 Stability Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 30 Drug Substance Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 31 Stability Indicating Method Validation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 32 Accelerated Stability Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 33 Photostability Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 34 Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 35 Others Service Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 36 Pharmaceutical Analytical Testing Services in CRO Market: End Use outlook and key takeaways
Fig. 37 Pharmaceutical Analytical Testing Services in CRO Market: End Use movement analysis
Fig. 38 Pharmaceutical Companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 39 Biopharmaceutical Companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 40 Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 41 Regional Marketplace: Key Takeaways
Fig. 42 North America Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 43 U.S. Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 44 Canada Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 45 Mexico Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 46 Europe Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 47 UK Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 48 Germany Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 49 France Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 50 Italy Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 51 Spain Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 52 Sweden Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 53 Denmark Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 54 Norway Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 55 Poland Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 56 Switzerland Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 57 Austria Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 58 Czech Republic Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 59 Croatia Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 60 Slovenia Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 61 Greece Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 62 Asia Pacific Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 63 Japan Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 64 China Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 65 India Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 66 Thailand Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 67 South Korea Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 68 Australia Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 69 Latin America Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 70 Brazil Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 71 Argentina Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 72 Middle East & Africa Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 73 South Africa Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 74 Saudi Arabia Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 75 UAE Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 76 Kuwait Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 77 Oman Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 78 Qatar Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
提及公司
同分類最新報告（醫療器材）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Grand View Research 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們